METASTATIC UVEAL MELANOMA
Clinical trials for METASTATIC UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug duo tame a rare eye cancer that has spread?
Disease control TerminatedThis trial is testing whether combining two drugs—pembrolizumab and lenvatinib—can help people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. Participants receive both drugs for up to two years. The study measures how long people liv…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control TerminatedThis early-stage trial tested a modified virus (VSV-IFNbetaTYRP1) in 12 patients with advanced melanoma that had spread or could not be removed by surgery. The virus was designed to infect and kill melanoma cells while also boosting the immune system's attack. The main goals were…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC